| 12448457 |
GP130 binding molecules and methods of use |
Deepti Rokkam, Patrick J. Lupardus, Sandro Vivona |
2025-10-21 |
|
| 12297281 |
IL10RA binding molecules and methods of use |
Deepti Rokkam, Patrick J. Lupardus, Sandro Vivona |
2025-05-13 |
|
| 12291572 |
IL12 receptor synthetic cytokines and methods of use |
Deepti Rokkam, Patrick J. Lupardus |
2025-05-06 |
|
| 12286482 |
IL10RB binding molecules and encoding nucleic acids |
Sandro Vivona, Deepti Rokkam, Patrick J. Lupardus |
2025-04-29 |
|
| 12234291 |
IL2RB binding molecules and methods of use |
Deepti Rokkam, Patrick J. Lupardus, Sandro Vivona |
2025-02-25 |
|
| 12209132 |
Compositions and methods related to IL27 receptor binding |
Patrick J. Lupardus, Deepti Rokkam |
2025-01-28 |
|
| 12157773 |
IL27RAlpha binding molecules and methods of use |
Deepti Rokkam, Patrick J. Lupardus, Sandro Vivona |
2024-12-03 |
|
| 12139545 |
IL10 receptor binding molecules and methods of use |
Mahalakshmi Ramadass, Deepti Rokkam, Patrick J. Lupardus, Sandro Vivona |
2024-11-12 |
|
| 12122839 |
IFNGR binding synthetic cytokines and methods of use |
Deepti Rokkam, Patrick J. Lupardus |
2024-10-22 |
|
| 12077594 |
IL2RG binding molecules and methods of use |
Deepti Rokkam, Patrick J. Lupardus, Sandro Vivona |
2024-09-03 |
|
| 12018085 |
Interferon-gamma R2 (IFNGR2) binding molecules comprising single-domain antibodies and method of use thereof to treat autoimmune and inflammatory diseases |
Patrick J. Lupardus, Deepti Rokkam |
2024-06-25 |
|
| 12012457 |
IL23R binding molecules and methods of use |
Patrick J. Lupardus, Deepti Rokkam |
2024-06-18 |
|
| 11918648 |
Combination of a PD-1 antagonist and CpG-C type oligonucleotide for treating cancer |
Ying Yu, Andrew Evan Denker, Svetlana Sadekova, Uyen Phan, David KAUFMAN +3 more |
2024-03-05 |
$186,921,000 |
| 11873349 |
Compositions and methods related to IL27 receptor binding |
Patrick J. Lupardus, Deepti Rokkam |
2024-01-16 |
|
| 11859001 |
IL12RB1-Binding molecules and methods of use |
Deepti Rokkam, Patrick J. Lupardus, Sandro Vivona |
2024-01-02 |
|
| 11052065 |
Compositions and methods for treating cancer with a combination of programmed death receptor (PD-1) antibodies and a CXCR2 antagonist |
Elaine M. Pinheiro, Michael Rosenzweig, David KAUFMAN, Deborah Law |
2021-07-06 |
$119,175,000 |
| 10751412 |
Combination of a PD-1 antagonist and CPG-C type oligonucleotide for treating cancer |
Ying Yu, Andrew Evan Denker, Svetlana Sadekova, Uyen Phan, David KAUFMAN +3 more |
2020-08-25 |
$403,892,000 |
| 9970944 |
Methods of modulating cytokine activity; related reagents |
Jochen Schmitz, Martin Oft, J. Fernando Bazan |
2018-05-15 |
$97,235,000 |
| 8795666 |
Antagonists of IL-23P19 for treatement of atopic dermatitis |
Madaline Chirica, Kevin W. Moore, Christi L. Parham |
2014-08-05 |
$53,413,000 |
| 8691953 |
Binding compounds for IL-27 |
Jacqueline C. Timans, Stefan Pflanz, J. Fernando Bazan, Donna Rennick, Rene de Waal Malefyt +1 more |
2014-04-08 |
$55,924,000 |
| 8586035 |
Use of IL-23 antagonists for treatment of infection |
Manfred Kopf, Luigina Romani, Alissa A. Chackerian |
2013-11-19 |
$50,784,000 |
| 8524230 |
Use of IL-23 and IL-17 antagonists to treat autoimmune ocular inflammatory disease |
Daniel J. Cua, Van To Tsai, Rachel Caspi, Phyllis Silver |
2013-09-03 |
$73,082,000 |
| 8372402 |
Mammalian receptor proteins DCRS5; methods of treatment |
Madaline Chirica, Kevin W. Moore, Christi L. Parham |
2013-02-12 |
$75,021,000 |
| 8187596 |
Method of treating asthma or allergy by administering an IL-33 receptor antibody |
Alissa A. Chackerian |
2012-05-29 |
|
| 8178095 |
Method of treating skin inflammation |
Terrill K. McClanahan, Erin Murphy, Jason R. Chan |
2012-05-15 |
|
